Cui Cui
Stock Analyst at Jefferies
(4.41)
# 1,223
Out of 4,673 analysts
34
Total ratings
59.4%
Success rate
32.5%
Average return
Main Sectors:
Stocks Rated by Cui Cui
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 1548 Genscript Biotech Corporation | Maintained: Buy | $15.50 → $30.00 | $34.44 | -12.89% | 2 | Aug 20, 2026 | |
| HKG: 6618 JD Health International Inc. | Maintained: Buy | $88.00 → $80.00 | $38.66 | +106.93% | 4 | Aug 17, 2026 | |
| HKG: 0241 Alibaba Health Information Technology Limited | Maintained: Buy | $8.00 → $5.30 | $3.26 | +62.58% | 2 | May 19, 2026 | |
| HKG: 9966 Alphamab Oncology | Maintained: Buy | $9.60 | $8.18 | +17.36% | 1 | Mar 27, 2026 | |
| HKG: 1833 Ping An Healthcare and Technology Company Limited | Maintained: Hold | $12.40 | $6.74 | +84.11% | 1 | Mar 25, 2026 | |
| HKG: 9926 Akeso, Inc. | Maintained: Buy | $226.00 | $90.25 | +150.42% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Maintained: Buy | $500.00 | $194.50 | +157.07% | 2 | Oct 8, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $300.00 → $520.00 | $538.00 | n/a | 3 | Aug 19, 2025 | |
| HKG: 1093 CSPC Pharmaceutical Group Limited | Maintained: Sell | $5.00 | $9.19 | n/a | 1 | Jul 30, 2025 | |
| HKG: 2269 WuXi Biologics (Cayman) Inc. | Maintained: Buy | $45.00 | $51.00 | n/a | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $41.00 → $60.00 | $71.65 | n/a | 2 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175.00 → $87.40 | $205.80 | n/a | 2 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 | $102.40 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4.00 | $2.23 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10.80 | $7.71 | n/a | 1 | Jan 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26.00 | $16.65 | n/a | 1 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110.00 | $40.00 | n/a | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40.00 → $35.20 | $24.92 | n/a | 2 | Oct 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.00 → $25.00 | $33.08 | n/a | 2 | Sep 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $10.00 | $17.83 | n/a | 1 | Apr 22, 2020 |
Genscript Biotech Corporation
Aug 20, 2026
Maintained: Buy
Price Target: $15.50 → $30.00
Current: $34.44
Upside: -12.89%
JD Health International Inc.
Aug 17, 2026
Maintained: Buy
Price Target: $88.00 → $80.00
Current: $38.66
Upside: +106.93%
Alibaba Health Information Technology Limited
May 19, 2026
Maintained: Buy
Price Target: $8.00 → $5.30
Current: $3.26
Upside: +62.58%
Alphamab Oncology
Mar 27, 2026
Maintained: Buy
Price Target: $9.60
Current: $8.18
Upside: +17.36%
Ping An Healthcare and Technology Company Limited
Mar 25, 2026
Maintained: Hold
Price Target: $12.40
Current: $6.74
Upside: +84.11%
Akeso, Inc.
Oct 19, 2025
Maintained: Buy
Price Target: $226.00
Current: $90.25
Upside: +150.42%
Duality Biotherapeutics, Inc.
Oct 8, 2025
Maintained: Buy
Price Target: $500.00
Current: $194.50
Upside: +157.07%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Aug 19, 2025
Maintained: Buy
Price Target: $300.00 → $520.00
Current: $538.00
Upside: n/a
CSPC Pharmaceutical Group Limited
Jul 30, 2025
Maintained: Sell
Price Target: $5.00
Current: $9.19
Upside: n/a
WuXi Biologics (Cayman) Inc.
Mar 31, 2025
Maintained: Buy
Price Target: $45.00
Current: $51.00
Upside: n/a
Mar 27, 2025
Maintained: Buy
Price Target: $41.00 → $60.00
Current: $71.65
Upside: n/a
Mar 21, 2025
Maintained: Buy
Price Target: $175.00 → $87.40
Current: $205.80
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $40.00
Current: $102.40
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $4.00
Current: $2.23
Upside: n/a
Jan 22, 2025
Maintained: Buy
Price Target: $10.80
Current: $7.71
Upside: n/a
Nov 3, 2023
Maintained: Buy
Price Target: $26.00
Current: $16.65
Upside: n/a
Oct 31, 2023
Maintained: Buy
Price Target: $110.00
Current: $40.00
Upside: n/a
Oct 27, 2023
Maintained: Buy
Price Target: $40.00 → $35.20
Current: $24.92
Upside: n/a
Sep 4, 2023
Maintained: Buy
Price Target: $28.00 → $25.00
Current: $33.08
Upside: n/a
Apr 22, 2020
Downgraded: Hold
Price Target: $10.00
Current: $17.83
Upside: n/a